Voyager Therapeutics Inc (VYGR) Insider Trading
- $92,031,920.32
- $16,140,019.47
- Oct. 2, 2024
- Bernard Ravina
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Oct. 2, 2024 | Insider | 5,999 | $5.82 | Sell | $34,914.18 | |
Jan. 17, 2024 | COO | 2,543 | $7.15 | Sell | $18,182.45 | |
Jan. 17, 2024 | Insider | 1,266 | $7.18 | Sell | $9,089.88 | |
Oct. 3, 2023 | CFO | 13,567 | $6.99 | Sell | $94,833.33 | |
Sept. 15, 2023 | Insider | 10,500 | $8.16 | Sell | $85,680.00 | |
July 6, 2023 | Insider | 5,500 | $10.80 | Sell | $59,400.00 | |
April 3, 2023 | CEO | 7,437 | $7.83 | Sell | $58,231.71 | |
April 3, 2023 | COO | 1,259 | $7.83 | Sell | $9,857.97 | |
March 20, 2023 | COO | 3,654 | $7.76 | Sell | $28,355.04 | |
March 20, 2023 | Insider | 2,193 | $7.76 | Sell | $17,017.68 | |
March 20, 2023 | VP | 4,410 | $7.76 | Sell | $34,221.60 | |
Feb. 23, 2023 | Major Shareholder | 4,395,588 | $8.88 | Buy | $39,032,821.44 | |
Feb. 17, 2023 | Insider | 738 | $7.45 | Sell | $5,498.10 | |
Feb. 17, 2023 | VP | 3,297 | $7.45 | Sell | $24,562.65 | |
Feb. 13, 2023 | VP | 2,868 | $7.67 | Sell | $21,997.56 | |
Feb. 13, 2023 | Insider | 797 | $7.67 | Sell | $6,112.99 | |
Feb. 1, 2023 | Major Shareholder | 128,642 | $9.32 | Sell | $1,198,943.44 | |
Jan. 30, 2023 | Major Shareholder | 75,000 | $9.03 | Sell | $677,250.00 | |
Jan. 27, 2023 | Major Shareholder | 50,000 | $9.02 | Sell | $451,000.00 | |
Jan. 25, 2023 | Major Shareholder | 50,000 | $9.22 | Sell | $461,000.00 | |
Jan. 23, 2023 | Major Shareholder | 55,000 | $9.06 | Sell | $498,300.00 | |
Jan. 20, 2023 | Major Shareholder | 100,000 | $9.15 | Sell | $915,000.00 | |
Jan. 17, 2023 | VP | 2,188 | $9.85 | Sell | $21,551.80 | |
Jan. 17, 2023 | Insider | 1,106 | $9.85 | Sell | $10,894.10 | |
Jan. 11, 2023 | Major Shareholder | 110,000 | $8.50 | Sell | $935,000.00 | |
Jan. 9, 2023 | Major Shareholder | 456,000 | $7.67 | Sell | $3,497,520.00 | |
Aug. 24, 2022 | Major Shareholder | 149,972 | $6.09 | Sell | $913,329.48 | |
Aug. 15, 2022 | Major Shareholder | 135,808 | $6.04 | Sell | $820,280.32 | |
Aug. 12, 2022 | Major Shareholder | 348,007 | $6.12 | Sell | $2,129,802.84 | |
July 14, 2022 | N/A | 9,512 | $6.70 | Sell | $63,730.40 | |
July 14, 2022 | Director | 9,512 | $6.70 | Sell | $63,730.40 | |
July 14, 2022 | N/A | 13,891 | $6.70 | Sell | $93,069.70 | |
June 23, 2022 | Major Shareholder | 376,000 | $5.66 | Buy | $2,128,160.00 | |
June 21, 2022 | Major Shareholder | 101,400 | $5.28 | Buy | $535,392.00 | |
April 4, 2022 | VP | 2,786 | $8.25 | Sell | $22,984.50 | |
April 4, 2022 | COO | 1,527 | $8.25 | Sell | $12,597.75 | |
March 21, 2022 | VP | 4,955 | $8.29 | Sell | $41,076.95 | |
March 21, 2022 | COO | 4,413 | $8.29 | Sell | $36,583.77 | |
Feb. 11, 2022 | VP | 3,252 | $3.36 | Sell | $10,926.72 | |
Jan. 12, 2022 | VP | 265 | $3.06 | Sell | $810.90 | |
Jan. 3, 2022 | VP | 3,063 | $2.83 | Sell | $8,668.29 | |
Jan. 12, 2021 | CFO | 2,942 | $8.62 | Sell | $25,360.04 | |
Jan. 12, 2021 | CEO | 10,443 | $8.62 | Sell | $90,018.66 | |
May 21, 2020 | Insider | 3,500 | $12.96 | Sell | $45,360.00 | |
April 3, 2020 | VP | 3,091 | $8.51 | Sell | $26,304.41 | |
Jan. 21, 2020 | CFO | 3,128 | $13.36 | Sell | $41,790.08 | |
Jan. 21, 2020 | COO | 3,724 | $13.36 | Sell | $49,752.64 | |
Jan. 21, 2020 | CEO | 10,705 | $13.36 | Sell | $143,018.80 | |
March 12, 2019 | Major Shareholder | 4,179,728 | $11.96 | Buy | $49,989,546.88 | |
Sept. 12, 2018 | Director | 5,000 | $18.44 | Buy | $92,200.00 |
Insiders are both buying and selling Voyager Therapeutics Inc stock.
The insider traders at Voyager Therapeutics Inc are: Bernard Ravina, Rock Ventures Iii L.P. Third, Robert W Hesslein, Todd Alfred Carter, Robin Swartz, Ecor1 Capital, Llc, Jane Henderson, Neurocrine Biosciences Inc, Glenn Pierce, Andre Turenne, James A Geraghty, Julie Burek, Allison Dorval, Matthew P Ottmer, Dinah Ph.D. Sah, Higgins Michael J, Alfred Sandrock, Omar Khwaja, Peter P Pfreundschuh, PIERCE GLENN, Sandell Jacquelyn Fahey, and Steven M Paul
The most active insider trader at Voyager Therapeutics Inc is Bernard Ravina with 10 trades.
Rock Ventures Iii L.P. Third has sold the most Voyager Therapeutics Inc stock with a total value of $9,263,849.52.
Neurocrine Biosciences Inc has bought the most Voyager Therapeutics Inc stock with a total value of $128,055,189.76.
The most recent insider trade for Voyager Therapeutics Inc was on Oct. 2, 2024.
The single biggest insider buy for Voyager Therapeutics Inc was from Neurocrine Biosciences Inc with a total value of $49,989,546.88 on March 12, 2019.
The single biggest insider sell for Voyager Therapeutics Inc was from Ecor1 Capital, Llc with a total value of $3,497,520.00 on Jan. 9, 2023.